Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. https://doi.org/10.4193/rhin20.600.
Lin DC, Chandra RK, Tan BK, Zirkle W, Conley DB, Grammer LC, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25(4):205–8. https://doi.org/10.2500/ajra.2011.25.3613.
Sanchez-Collado I, Mora T, Munoz-Cano R, Ribo P, Mullol J, Valero A. Prevalence of chronic rhinosinusitis with nasal polyps in Catalonia (Spain): a retrospective, large-scale population-based study. Rhinology. 2022;60(5):384–96. https://doi.org/10.4193/rhin21.364.
Article CAS PubMed Google Scholar
Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449-1456.e4. https://doi.org/10.1016/j.jaci.2015.12.1324.
Article CAS PubMed Google Scholar
Bachert C, Marple B, Hosemann W, Cavaliere C, Wen W, Zhang N. Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications. J Allergy Clin Immunol Pract. 2020;8(5):1514–9. https://doi.org/10.1016/j.jaip.2020.03.007.
Cardell LO, Stjärne P, Jonstam K, Bachert C. Endotypes of chronic rhinosinusitis: Impact on management. J Allergy Clin Immunol. 2020;145(3):752–6. https://doi.org/10.1016/j.jaci.2020.01.019.
Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler ZM. Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol. 2015;136(6):1532-1540.e2. https://doi.org/10.1016/j.jaci.2015.10.012.
C Morse J, Miller C, Senior B. Management of chronic rhinosinusitis with nasal polyposis in the era of biologics. J Asthma Allergy. 2021;14:873–82. https://doi.org/10.2147/jaa.s258438.
Chen FH, Deng J, Hong HY, Xu R, Guo JB, Hou WJ, et al. Extensive versus functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma: A 1-year study. Am J Rhinol Allergy. 2016;30(2):143–8. https://doi.org/10.2500/ajra.2016.30.4271.
Alsharif S, Jonstam K, van Zele T, Gevaert P, Holtappels G, Bachert C. Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study. Laryngoscope. 2019;129(6):1286–92. https://doi.org/10.1002/lary.27815.
Moreno-Luna R, Martin-Jimenez DI, Callejon-Leblic MA, Gonzalez-Garcia J, Maza-Solano JM, Porras-Gonzalez C, et al. Usefulness of bilateral mucoplasty plus reboot surgery in severe type-2 chronic rhinosinusitis with nasal polyps. Rhinology. 2022;60(5):368–76. https://doi.org/10.4193/rhin22.131.
Article CAS PubMed Google Scholar
•• Bachert C, Maurer M, Palomares O, Busse WW. What is the contribution of IgE to nasal polyposis? J Allergy Clin Immunol. 2021;147(6):1997–2008. https://doi.org/10.1016/j.jaci.2021.03.016. Outcomes of this review reinforce the role of IgE as a central mediator of type 2 eosinophil-dominated inflammation in nasal polyposis, which may be inferred from the efficacy of omalizumab.
Ren L, Zhang N, Zhang L, Bachert C. Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art. World Allergy Organ J. 2019;12(8):100050. https://doi.org/10.1016/j.waojou.2019.100050.
Zhang N, Holtappels G, Gevaert P, Patou J, Dhaliwal B, Gould H, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy. 2011;66(1):141–8. https://doi.org/10.1111/j.1398-9995.2010.02448.x.
Article CAS PubMed Google Scholar
Kartush AG, Schumacher JK, Shah R, Patadia MO. Biologic agents for the treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(2):203–11. https://doi.org/10.1177/1945892418814768.
Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145(3):725–39. https://doi.org/10.1016/j.jaci.2020.01.020.
Article CAS PubMed Google Scholar
Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48(3):318–24. https://doi.org/10.4193/rhino09.144.
Article CAS PubMed Google Scholar
Wu Q, Yuan L, Qiu H, Wang X, Huang X, Zheng R, et al. Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021;11(9):e047344. https://doi.org/10.1136/bmjopen-2020-047344.
Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605. https://doi.org/10.1016/j.jaci.2020.05.032.
Article CAS PubMed Google Scholar
Bajpai S, Marino MJ, Rank MA, Donaldson AM, O’Brien EK, Lal D. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: a real-world study. Int Forum Allergy Rhinol. 2021;11(8):1152–61. https://doi.org/10.1002/alr.22774.
Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110-116.e1. https://doi.org/10.1016/j.jaci.2012.07.047.
Article CAS PubMed Google Scholar
Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194–202. https://doi.org/10.4193/rhin22.489.
Article CAS PubMed Google Scholar
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. https://doi.org/10.1002/alr.22741.
Alobid I, Colás C, Castillo JA, Arismendi E, Del Cuvillo A, Gómez-Outes A, et al. Spanish consensus on the management of chronic rhinosinusitis with nasal polyps (POLIposis NAsal / POLINA 2.0). J Investig Allergol Clin Immunol. 2023;0. Online ahead of print. https://doi.org/10.18176/jiaci.0910.
Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol. 2017;140(4):1024-1031.e14. https://doi.org/10.1016/j.jaci.2017.05.044.
Article CAS PubMed Google Scholar
Hopkins C, Wagenmann M, Bachert C, Desrosiers M, Han JK, Hellings PW, et al. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(7):1087–101. https://doi.org/10.1002/alr.22780.
Article PubMed PubMed Central Google Scholar
Miglani A, Soler ZM, Smith TL, Mace JC, Schlosser RJ. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2023;13(2):116–28. https://doi.org/10.1002/alr.23059.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:3 p preceding table of contents, 1–298.
Global Initiative for Asthma - GINA. In: Global Initiative for Asthma. 2022. https://ginasthma.org/. Accessed 5 April 2023.
Rudmik L, Soler ZM, Hopkins C, Schlosser RJ, Peters A, White AA, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Rhinology. 2016;54(2):117–28. https://doi.org/10.4193/rhino16.023.
Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016;54(2):129–33. https://doi.org/10.4193/rhino15.072.
Doulaptsi M, Prokopakis E, Seys S, Pugin B, Steelant B, Hellings P. Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl Allergy. 2018;8:32. https://doi.org/10.1186/s13601-018-0219-6.
Article PubMed PubMed Central Google Scholar
Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(5 Suppl):S17-61. https://doi.org/10.1016/j.jaci.2006.09.005.
Psaltis AJ, Li G, Vaezeafshar R, Cho KS, Hwang PH. Modification of the Lund-Kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures. Laryngoscope. 2014;124(10):2216–23. https://doi.org/10.1002/lary.24654.
Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2007;137(4):555–61. https://doi.org/10.1016/j.otohns.2007.02.004.
Tiotiu A, Oster JP, Roux PR, Nguyen Thi PL, Peiffer G, Bonniaud P, et al. Effectiveness of omalizumab in severe allergic asthma and nasal polyposis: a real-life study. J Investig Allergol Clin Immunol. 2020;30(1):49–57. https://doi.org/10.18176/jiaci.0391.
• Damask C, Chen M, Holweg CTJ, Yoo B, Millette LA, Franzese C. Defining the efficacy of omalizumab in nasal polyposis: a POLYP 1 and POLYP 2 subgroup analysis. Am J Rhinol Allergy. 2022;36(1):135–41. https://doi.org/10.1177/19458924211030486. Findings suggest broad efficacy of omalizumab across clinical and patient-reported outcomes in patients with CRSwNP, independent of the underlying patient features analyzed.
Han JK, Yoo B, Saenz R, Braid J, Millette LA, Lee SE. Omalizumab and quality of life in nasal polyps: a post hoc analysis. Int Forum Allergy Rhinol. 2022;12(9):1188–90. https://doi.org/10.1002/alr.22963.
Huang Y, Zhang N, Xu Z, Zhang L, Bachert C. The development of the mucosal concept in chronic rhinosinusitis and its clinical implications. J Allergy Clin Immunol Pract. 2022;10(3):707–15. https://doi.org/10.1016/j.jaip.2021.10.054.
Jonstam K, Alsharif S, Bogaert S, Suchonos N, Holtappels G, Jae-Hyun Park J, et al. Extent of inflammation in severe nasal polyposis and effect of sinus surgery on inflammation. Allergy. 2021;76(3):933–6. https://doi.org/10.1111/all.14550.
López-Enríquez S, Porras-González C, Moreno-Luna R, Ebert CS, Alba G, Santa-María C, et al. Tissue-specific activated regulatory lymphocytes immunophenotype in chronic rhinosinusitis with nasal polyps. Arch Bronconeumol. 2023;59(5):337–40. https://doi.org/10.1016/j.arbres.2022.12.013.
Kobayashi Y, Kanda A, Bui DV, Yun Y, Nguyen LM, Chu HH, et al. Omalizumab restores response to corticosteroids in patients with eosinophilic chronic rhinosinusitis and severe asthma. Biomedicines. 2021;9(7):787. https://doi.org/10.3390/biomedicines9070787.
Comments (0)